How Effective Are DHT Blockers for Hair Regrowth
How effective are DHT blockers at stopping hair loss and regrowing hair?
Ask whether DHT blockers work and you're really asking two questions, and they don't get the same answer. Holding on to what you've still got is the strong claim, backed by multi-year trials where roughly nine in ten men showed no further measurable loss. Getting hair back is the weaker claim, and it's the one the advertising leans on hardest.
| What you're asking | Stopping the loss | Growing hair back |
|---|---|---|
| Odds over five years | About 9 in 10 hold | About 2 in 3 gain count |
| Size of the effect | No further measurable loss | Roughly 10% more hairs in the target zone |
| Would anyone else notice | You keep looking like you do now | Only a smaller share, without photos |
| Where it works best | Anywhere still growing | Vertex and mid-scalp |
DHT suppression holds the line for roughly nine in ten men across five years, while about two thirds see a measurable count gain of around ten percent in the target zone.
What does the clinical evidence show about hair count changes with DHT-lowering therapy?
The numbers everyone quotes come from a small tattooed circle on the scalp that gets photographed at every visit, so the same square centimetres are counted every time. That's a precise way to measure, and it's also why the counts run a little ahead of what you'd see in the mirror, since a fine vellus hair scores the same as a thick one. What makes the data convincing isn't the treated group's own gain. It's the untreated group sliding the other way for five straight years.
- Year-one gain: About 91 hairs added inside a one-inch circle, off a baseline near 876.
- Peak count: Year two, where improvement over the starting count tops out.
- The real gap: Untreated scalps kept dropping, so the five-year separation dwarfs the treated gain.
- Dual-isoform suppression: Cuts serum DHT around 95 percent against roughly 70, for a modest count edge.
Treated men gained roughly 91 hairs inside a one-inch target circle by month twelve from a starting count near 876, while the untreated comparison group kept losing.
How much of the benefit is holding on to existing hair versus growing new hair back?
Most people picture regrowth as dormant follicles waking up, and that's the smaller half of the story. What usually happens is that a thin, wispy hair you already had returns to a fuller diameter and a longer growth phase, which reads on a photo as new coverage even though nothing new was recruited. Where a follicle has already been replaced by fibrous tissue, there's nothing left to rescue, which is why how long you've been losing predicts your result better than almost anything else.
Holding ground is the larger share of the value by a wide margin, because the honest comparison isn't against today's scalp but against where that scalp would be in five or ten years untreated.
What happens to the gains when the treatment is stopped?
Here's the part that decides whether this treatment is right for you, and it's better to face it on day one than in year three. Nothing about DHT suppression is permanent, and the unwind is faster than most people expect. The good news is that stopping doesn't leave you worse off than your true baseline; it just drops you back onto the trajectory you were always on, several years further along it.
- Within weeks: Scalp dihydrotestosterone climbs back toward baseline once the dosing stops.
- Months two to four: Shedding becomes noticeable as hairs shift out of their extended growth phase.
- Around month twelve: Density converges on what it would have been if you'd never treated at all.
- Restarting later: You recover some of it, but follicles lost to scarring during the gap are gone for good.
Scalp DHT returns to baseline within weeks of stopping and the accumulated benefit is typically gone within about twelve months, putting the scalp back on the trajectory it would have followed anyway.
How long does it take before any visible change appears, and when is the result final?
The follicle sets this timeline, not the drug. Hormone levels in the scalp drop within days, but a follicle still has to finish its resting phase, re-enter growth, and push a shaft up through the skin, and you can't compress that sequence. Plan for a slow, unimpressive first few months and don't judge anything until you've got twelve months and matching photographs.
Nothing is visible for the first three to four months, a fair first assessment belongs at month six, month twelve is decision-grade, and most of the total gain is banked within the first two years.
Do oral and topical routes differ in how much they lower scalp DHT and in the results they produce?
Topical dosing was built to separate scalp suppression from whole-body suppression, and it partly pulls that off. The word that matters is partly: meaningful amounts still cross the skin and reach circulation, so you're reducing systemic exposure, not switching it off. Choose by what you're prioritising rather than by which one is better, because they're strong in different places.
| Criteria | Oral | Topical |
|---|---|---|
| Serum DHT drop | About 56 percent | About 35 percent |
| Systemic exposure | Full body, comparable to scalp | Reduced, not eliminated |
| Target-area hair counts | The reference standard | Non-inferior in better-designed work |
| Depth of evidence | Large, long, repeated trials | Fewer, shorter, smaller studies |
| Batch consistency | Licensed manufacture | Varies where compounded |
Topical application cut serum dihydrotestosterone by about thirty-five percent against about fifty-six percent for the oral tablet, and tested non-inferior on target-area hair counts on a thinner body of evidence.
How does effectiveness change with age, how long the hair has been gone, and how advanced the thinning is?
Age gets the blame here, but it's mostly standing in for duration. A twenty-six year old who noticed thinning eighteen months ago is treating a scalp full of shrunken but living follicles; a fifty-six year old with thirty years of loss is treating zones where the follicle has already gone. Run a light over the thinning area and look for short, fine, pale hairs, because that tells you more than your birth year does.
How long the hair has been gone predicts response better than age does, and once the skin is genuinely smooth and shiny no amount of hormone suppression recruits a follicle that's no longer there.
Which areas of the scalp respond to DHT suppression and which do not?
Your scalp isn't one tissue, and the difference was set before you were born. Follicles in the crown carry the heaviest load of androgen receptors and the converting enzyme, so they take the most damage from the hormone and gain the most when you remove it. The front is the stubborn zone, and knowing that up front is what keeps you from judging a working treatment by the one area least likely to move.
The crown and mid-scalp carry the highest androgen receptor and enzyme density and produced most of the regrowth measured in the trials, while the frontal hairline and temples respond far less and the back and sides aren't affected at all.
Does pairing a DHT blocker with a growth stimulant change the outcome?
This is one of the few genuinely additive moves in hair loss, because the two aren't doing the same job. Suppression removes the cause of the shrinking; a vasodilating stimulant ignores the cause and simply extends the growth phase and fattens the shaft. Stack them and the blocker holds the line while the stimulant makes what survives look thicker.
- Independent pathways: One removes the hormonal cause, the other extends growth and shaft diameter.
- Stagger the start: Begin them a month or two apart so the sheds don't stack in month three.
- Adherence is the real cost: A twice-daily topical plus a daily tablet erodes over years.
- If something has to go: Drop the adjuncts, then the stimulant. Never the blocker.
Pooled trial data shows a growth stimulant paired with a blocker outperforms the stimulant alone on blinded global photographic assessment, because the two act through independent pathways.
What proportion of users see no meaningful benefit, and why does that happen?
I don't want you writing off a treatment that's working, and month four is where most people do exactly that. Roughly one in ten men in the long-term trials kept losing ground despite treatment, and a little over four in ten stabilised without regrowth they'd call meaningful. Before you call yours a failure, three far more common explanations need ruling out first.
- The diagnosis: Shedding from thyroid disease, low iron, recent illness, or rapid weight loss isn't androgen-driven and won't respond to androgen suppression.
- Dosing and timing: Inconsistent dosing leaves suppression incomplete, and judging the result at month four lands you in the middle of the shed.
- No month-zero photograph: Without one, you're comparing your scalp against a memory that quietly flatters itself.
- Genuine non-response: Enzyme and receptor variation is real, no routine test predicts it, and deeper dual-isoform suppression rescues some of these people.
About one in ten men on long-term treatment continued to lose ground and a little over four in ten stabilised without regrowth they considered meaningful.
How is effectiveness measured in trials compared with what a person actually sees in the mirror?
A trial endpoint and your bathroom mirror are answering two different questions, and that's why a solid result can feel like nothing happened. Counts add up hairs; your eye reads the cross-sectional area of the shafts, so doubling one hair's diameter does far more for how full you look than adding another wispy one beside it. Copy what the trials do rather than what your mood suggests, and the question settles itself at month twelve.
| Criteria | The trial count | Your mirror |
|---|---|---|
| What gets counted | Every pigmented hair in a tattooed circle | The combined thickness of what you can see |
| A fine vellus hair | Scores as one full hair | Adds almost nothing to coverage |
| Conditions | Same light, angle, dry hair, every visit | Changing light, often wet hair |
| The baseline | A month-zero photograph | A memory that updates itself |
Trial counts score a fine vellus hair and a thick terminal hair as one unit each, while perceived density tracks the cross-sectional area of the shafts, which is why a statistically robust result can look cosmetically underwhelming.
Do plant-derived blockers have evidence comparable to the prescription drugs?
The honest answer is no, and the gap is about scale as much as strength. The most studied botanical does inhibit the enzyme in a dish and has produced modest positive results in a handful of small human trials, while most of the rest of the category rests on cell cultures, animal work, or one small study apiece. There's a reasonable place for these if you've declined or can't tolerate prescription treatment, as long as nothing in that decision keeps an early-stage scalp away from something that would actually have held it.
- The head-to-head: 38 percent of the botanical group grew hair against 68 percent on the drug.
- Potency gap: Enzyme inhibition at high concentration in a dish barely registers at the scalp.
- No pre-market review: Content and labelling stay with the manufacturer, so batches vary.
- Shampoos: Rinsed off within a minute, with almost no chance to reach the follicle.
In the one two-year head-to-head comparison, thirty-eight percent of the botanical group showed increased hair growth against sixty-eight percent on the prescription drug, in a study that carried no untreated arm.
